Alan S. Roemer

Insider Reports History

Entity
Individual
Location
C/O Axovant Sciences, Inc., 1441 Broadway, 3 Rd Floor, New York, New York
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan S. Roemer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IN8BIO, INC. Director Common Stock 158K $163K $1.03 Dec 13, 2023 Direct
IN8BIO, INC. Director Series A Warrants (right to buy) 102K Dec 13, 2023 Direct
IN8BIO, INC. Director Series B Warrants (right to buy) 102K Dec 13, 2023 Direct
NexImmune, Inc. Director Stock Option (right to buy) 45K Jul 5, 2023 Direct
IN8BIO, INC. Director Stock Option (right to buy) 33.7K Jun 12, 2024 Direct
NexImmune, Inc. Director Common Stock 0 $1.94 Nov 22, 2023 Direct

Insider Reports Filed by Alan S. Roemer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INAB IN8BIO, INC. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
INAB IN8BIO, INC. Dec 13, 2023 3 $0 4 Dec 15, 2023 Director
NEXI NexImmune, Inc. Nov 21, 2023 2 -$16K 4 Nov 22, 2023 Director
NEXI NexImmune, Inc. Jul 5, 2023 1 $0 4 Jul 7, 2023 Director
INAB IN8BIO, INC. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
NEXI NexImmune, Inc. Apr 4, 2023 8 $0 4 Apr 6, 2023 Director
INAB IN8BIO, INC. Aug 16, 2022 1 $50K 4 Aug 18, 2022 Director
NEXI NexImmune, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
INAB IN8BIO, INC. Jun 1, 2022 1 $0 4/A Sep 23, 2022 Director
NEXI NexImmune, Inc. Dec 21, 2021 6 $246K 4 Dec 22, 2021 Director
INAB IN8BIO, INC. Nov 19, 2021 1 $0 4 Nov 23, 2021 Director
INAB IN8BIO, INC. Jul 29, 2021 1 $0 4 Aug 2, 2021 Director
INAB IN8BIO, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director